Indicated in the treatment of malignant lymphomas, acute lymphoplastic leukemia, hodgkins disease, astrocyroma, urinary blader carcinoma, and neuroblastoma. Dosage:monothera y 300 mg/mm for 3-5 days, repeted every 3 weeks.
Vial
14490 EGP
Indicated in the treatment of malignant lymphomas, acute lymphoplastic leukemia, hodgkins disease, astrocyroma, urinary blader carcinoma, and neuroblastoma. Dosage:monothera y 300 mg/mm for 3-5 days, repeted every 3 weeks.
Note: All the provided information about this drug does not substitute for consulting a doctor.